Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

915 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Integrated and automated high-throughput purification of libraries on microscale.
Ginsburg-Moraff C, Grob J, Chin K, Eastman G, Wildhaber S, Bayliss M, Mues HM, Palmieri M, Poirier J, Reck M, Luneau A, Rodde S, Reilly J, Wagner T, Brocklehurst CE, Wyler R, Dunstan D, Marziale AN. Ginsburg-Moraff C, et al. Among authors: poirier j. SLAS Technol. 2022 Aug 24:S2472-6303(22)05172-X. doi: 10.1016/j.slast.2022.08.002. Online ahead of print. SLAS Technol. 2022. PMID: 36028206 Free article.
Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.
Ozlen H, Pichet Binette A, Köbe T, Meyer PF, Gonneaud J, St-Onge F, Provost K, Soucy JP, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative, the Harvard Aging Brain Study, the Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease Research Group. Ozlen H, et al. Among authors: poirier j. JAMA Neurol. 2022 Aug 22:e222442. doi: 10.1001/jamaneurol.2022.2442. Online ahead of print. JAMA Neurol. 2022. PMID: 35994280
cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
Chemi F, Pearce SP, Clipson A, Hill SM, Conway AM, Richardson SA, Kamieniecka K, Caeser R, White DJ, Mohan S, Foy V, Simpson KL, Galvin M, Frese KK, Priest L, Egger J, Kerr A, Massion PP, Poirier JT, Brady G, Blackhall F, Rothwell DG, Rudin CM, Dive C. Chemi F, et al. Among authors: poirier jt. Nat Cancer. 2022 Aug 8. doi: 10.1038/s43018-022-00415-9. Online ahead of print. Nat Cancer. 2022. PMID: 35941262
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment.
Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, Buckley RF, Benzinger TLS, Morris JC, Villemagne VL, Doré V, Sperling RA, Johnson KA, Rowe CC, Gordon BA, Poirier J, Breitner JCS, Villeneuve S; PREVENT-AD, HABS, and AIBL Research Groups. Strikwerda-Brown C, et al. Among authors: poirier j. JAMA Neurol. 2022 Jul 30:e222379. doi: 10.1001/jamaneurol.2022.2379. Online ahead of print. JAMA Neurol. 2022. PMID: 35907254
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Korsen JA, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty N, Lewis JS. Korsen JA, et al. Among authors: poirier jt. Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2203820119. doi: 10.1073/pnas.2203820119. Epub 2022 Jun 27. Proc Natl Acad Sci U S A. 2022. PMID: 35759660 Free PMC article.
Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.
Bonnet-Serrano F, Poirier J, Vaczlavik A, Laguillier-Morizot C, Blanchet B, Baron S, Guignat L, Bessiene L, Bricaire L, Groussin L, Assié G, Guibourdenche J, Bertherat J. Bonnet-Serrano F, et al. Among authors: poirier j. Eur J Endocrinol. 2022 Jul 4;187(2):315-322. doi: 10.1530/EJE-22-0208. Print 2022 Aug 1. Eur J Endocrinol. 2022. PMID: 35699971
915 results